Milestone Scientific Corp (MLSS): Debts to Book Capitalization

Brandmark of Milestone Scientific Inc (MLSS)

How can clinics overcome their dependence on traditional anesthesia methods? An assessment of the debt-to-book capitalization ratio demonstrates financial stability dynamics, where the value of 0.19 reflects this status. Milestone Scientific (MLSS) addresses this issue through a digital ecosystem for comfortable injections, utilizing patented pressure control systems to reduce physician costs. Stable growth is secured by the protection of the CompuFlo niche, despite the slow adoption of innovations by medical professionals.

MLSS (Milestone Scientific Corporation) Debt to Book Value history from 07/04/2022 to 10/27/2026
Original product of Milestone Scientific Corporation

Milestone Scientific invests in a highly qualified staff of engineers and medical professionals to develop painless injections. This indicator measures the proportion of borrowed funds relative to equity, determining the degree of financial leverage. By analyzing the level of debt concentration within the balance sheet capitalization on GURU.Markets, an investor can see the real pressure of liabilities without market noise. Low values minimize default risk but limit the pace of scaling innovations. This allows for an assessment of the balance between security and aggressive business growth.

Who Milestone Scientific competes with

ISRG - Debts to Book Capitalization|Debt to Book Value Ratio danaher.com DHR|Debts to Book Capitalization BDX (Becton Dickinson)|STE - Debts to Net Assets|WST (West Pharmaceutical Services Inc) - Debts to Book Capitalization|Baxter Healthcare (BAX) - Debt to Book Value|MASI (Masimo Corporation) - Debts to Book Capitalization|Debts to Book Capitalization STVN|Debt to Book Capitalization Ratio Teleflex (TFX)|Debt to Book Capitalization Ratio Merit Medical Systems, Inc. MMSI|Debt to Book Value Envista Holdings Corp|Debt to Net Assets Ratio ICU Medical Inc. ICUI|Debts to Book Capitalization XRAY (DENTSPLY SIRONA Inc.)|LMAT: Debts to Net Assets|Debt to Book Capitalization Ratio AtriCure|STAA (STAAR Surgical Co.) - Debt to Book Value Ratio|NAGE: Debt to Book Capitalization Ratio|Debts to Net Assets ZimVie Corp (ZIMV)|Debt to Book Value AngioDynamics, Inc.|Debt to Book Capital CERS (cerus.com)|Debt to Book Capitalization Ratio Teknova|MGRM - Debt to Net Assets Ratio|Sharps Tech - Debt to Book Value|INFU: Debts to Book Capitalization|UTMD (Utah Medical Products) - Debt to Book Capitalization Ratio|KORU Medical (KRMD) - Debt to Book Value|Debts to Book Capitalization NYXH (Nyxoah)|Debts to Book Value MBOT|Debt to Book Capitalization Ratio Pro-Dex Corp PDEX|Debt to Book Value Ratio Zentek Corp ZTEK|Debt to Book Value Elutia Inc. (ELUT)|nexgel.com - Debt to Book Capital|Debt to Book Capitalization Ratio RVP (Retractable Tech)|HBIO: Debts to Net Assets|FEMY (Femasys Corp) - Debt to Book Capitalization Ratio|Meihua Medical Technologies Co., Ltd. (MHUA) - Debt to Book Value|POAI: Debts to Book Capitalization|Debts to Net Assets CJMB|Debt to Book Capitalization Ratio Atrion (ATRI)|Debt to Book Capitalization Ratio NeuroMetrix Inc (NURO)